Paraoxonase 1 192Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus
- 20 July 2004
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 21 (8), 837-844
- https://doi.org/10.1111/j.1464-5491.2004.01252.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Low paraoxonase activity in type II diabetes mellitus complicated by retinopathyClinical Science, 2000
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.JCI Insight, 1997
- Paraoxonase Genotypes, Lipoprotein Lipase Activity, and HDLArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Fibrinolysis and Diabetic Retinopathy in NIDDMDiabetes Care, 1995
- Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- European Atherosclerosis Research Study: Genotype at the Fibrinogen Locus (G −455 -A β-Gene) Is Associated With Differences in Plasma Fibrinogen Levels in Young Men and Women From Different Regions in EuropeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxificationChemico-Biological Interactions, 1993
- Studies on human serum paraoxonase/arylesteraseChemico-Biological Interactions, 1993
- Familial Clustering of Diabetic Kidney DiseaseThe New England Journal of Medicine, 1989
- BLOOD-VISCOSITY IN DIABETIC PATIENTSThe Lancet, 1966